![]() “His transformational leadership in the biopharmaceutical industry, deep knowledge, and global relationships will help the Foundation propel its vision of improving the lives of millions of people around the world with a variety of serious medical disorders. “We are pleased to welcome Bob among our exceptional group of Council members,” said Foundation Chairman Neal F. Celgene was ultimately acquired by Bristol-Myers Squibb in 2019. The Foundation is pleased to welcome Bob Hugin to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide strategic advice and assist with building awareness, establishing relationships, and raising funds.īob previously served as the Chairman and Chief Executive Officer of Celgene Corporation, where he led the strategic growth and global expansion of the biopharmaceutical anticancer company for nearly 20 years.
0 Comments
Leave a Reply. |